Which factor is considered when choosing screening intervals and tests?

• A. Patient age alone determines intervals.
• B. Costs exclusively determine what tests are used.
• C. Harms from screening are weighed in the net-benefit analysis when deciding intervals and tests.
• D. Public opinion drives screening recommendations.

Answer: (C)

In USPSTF guidance, choosing how often to screen and which tests to use is driven by the balance of benefits and harms—the net benefit. This means recommendations weigh not only the potential benefits of detecting disease early but also the downsides of screening, such as false positives, overdiagnosis, unnecessary procedures, anxiety, radiation exposure, and procedure-related harms. If the harms outweigh the benefits for a given interval or test, the net benefit is reduced and the recommendation may favor longer intervals or different testing strategies; if the benefits clearly exceed harms, more intensive screening may be advised. Therefore, harms from screening are explicitly weighed in the net-benefit analysis when deciding intervals and tests. While age, cost, and patient preferences can influence considerations, they do not override the net-benefit determination.